Genomic features beyond Chlamydia trachomatis phenotypes: What do we think we know?

被引:23
|
作者
Nunes, Alexandra [1 ]
Borrego, Maria J. [1 ]
Gomes, Joao P. [1 ]
机构
[1] Natl Inst Hlth, Dept Infect Dis, P-1649016 Lisbon, Portugal
关键词
Chlamydia trachomatis; Recombination; Point-mutation; Tissue tropism; Pathogenesis; Ecological success; OUTER-MEMBRANE PROTEIN; OBLIGATE INTRACELLULAR PATHOGEN; IN-VIVO; TISSUE TROPISM; GLYCOSAMINOGLYCAN BINDING; SALMONELLA-TYPHIMURIUM; TRYPTOPHAN SYNTHASE; DEVELOPMENTAL CYCLE; HOST-CELLS; GENE DECAY;
D O I
10.1016/j.meegid.2013.03.018
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The obligate intracellular pathogen Chlamydia trachomatis is the causative agent of the blinding trachoma and the world's leading cause of bacterial sexually transmitted infections. Despite aggressive antibacterial control measures, C trachomatis infections have been increasing, constituting a serious public health concern due to its morbidity and socioeconomic burden. Still, very little is known about the molecular basis underlying the phenotypic disparities observed among C trachomatis serovars in terms of tissue tropism (ocular conjunctiva, epithelial-genitalia and lymph nodes), virulence (disease outcomes) and ecological success. This is in part due to the inexistence of straightforward tools to genetically manipulate Chlamydiae and host cell-free growth systems, hampering the elucidation of the biological role of loci. The recent release of tenths of full-genome C trachomatis sequences depict a strains clustering scenario reflecting the organ/cell-type that they preferentially infect. However, the high degree of genomic conservation implies that few genetic features are involved in phenotypic dissimilarities. The purpose of this review is to gather the most relevant data dispersed throughout the literature concerning the genotypic evidences that support niche-specific phenotypes. This review focus on chromosomal dynamics phenomena like recombination and point-mutations, essentially involving outer and inclusion membrane proteins, type III secretion effectors, and hypothetical proteins with unknown function. The scrutiny of C trachomatis loci involved in tissue tropism, pathogenesis and ecological success is crucial for the development of disease-specific prophylaxis. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:392 / 400
页数:9
相关论文
共 50 条
  • [21] The pathogenesis of necrotic enteritis in chickens: what we know and what we need to know: a review
    Prescott, John F.
    Parreira, Valeria R.
    Gohari, Iman Mehdizadeh
    Lepp, Dion
    Gong, Joshua
    AVIAN PATHOLOGY, 2016, 45 (03) : 288 - 294
  • [22] What we know and still do not know about tick-borne encephalitis?
    Kriha, M. F.
    Chrdle, A.
    Ruzek, D.
    Chmelik, V
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2021, 70 (03): : 189 - 198
  • [23] What Can We Learn and What Do We Need to Know Amidst the Iatrogenic Outbreak of Exserohilum Rostratum Meningitis?
    Kontoyiannis, Dimitrios P.
    Perlin, David S.
    Roilides, Emmanuel
    Walsh, Thomas J.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (06) : 853 - 859
  • [24] Do We Know What Causes Eosinophilic Esophagitis? A Mechanistic Update
    Runge T.M.
    Dellon E.S.
    Current Gastroenterology Reports, 2015, 17 (9)
  • [25] The biology of chikungunya: A brief review of what we still do not know
    Pardigon, N.
    PATHOLOGIE BIOLOGIE, 2009, 57 (02): : 127 - 132
  • [26] Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?
    de la Maza, Luis M.
    Darville, Toni L.
    Pal, Sukumar
    EXPERT REVIEW OF VACCINES, 2021, 20 (04) : 425 - 439
  • [27] What do we know about actinides-proteins interactions?
    Creff, Gaelle
    Zurita, Cyril
    Jeanson, Aurelie
    Carle, Georges
    Vidaud, Claude
    Den Auwer, Christophe
    RADIOCHIMICA ACTA, 2019, 107 (9-11) : 993 - 1009
  • [28] Disease mechanisms in Sjogren's syndrome: What do we know?
    Jonsson, Roland
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2022, 95 (03)
  • [29] Female genital Chlamydia trachomatis infection: where are we heading?
    Mylonas, Ioannis
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2012, 285 (05) : 1271 - 1285
  • [30] What do we know about IDH1/2 mutations so far, and how do we use it?
    Horbinski, Craig
    ACTA NEUROPATHOLOGICA, 2013, 125 (05) : 621 - 636